These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ceftriaxone in the treatment of bacterial meningitis]. Duniewicz M; Stanková M; Absolonová V; Lochmann O; Potuzník V; Brezinová J; Havlík J Cas Lek Cesk; 1986 Aug; 125(35):1093-6. PubMed ID: 3757000 [No Abstract] [Full Text] [Related]
4. [Multicenter trials of a new cephalosporin (ceftriaxone) in childhood]. De Francesco F; Ciliberto R; Calcagno G; Fazio N; Scarcella L; Caruso P Pediatr Med Chir; 1985; 7(2):239-42. PubMed ID: 3912733 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone and otitis in children: new indication. Only in special circumstances. Prescrire Int; 2000 Aug; 9(48):99-102. PubMed ID: 11067716 [TBL] [Abstract][Full Text] [Related]
6. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children. Frenkel LD Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685 [TBL] [Abstract][Full Text] [Related]
7. A review of ceftriaxone: a long-acting cephalosporin. Stratton CW; Anthony LB; Johnston PE Am J Med Sci; 1988 Sep; 296(3):221-2. PubMed ID: 3052061 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics and clinical evaluation of ceftriaxone (CRO) in children with purulent meningitis. Mallet E; Leroy A; Lemeland JP Chemioterapia; 1987 Jun; 6(2 Suppl):427. PubMed ID: 3334589 [No Abstract] [Full Text] [Related]
10. Clinical pharmaceutics and calcium-ceftriaxone. Gin AS; Wheaton H; Dalton B Ann Pharmacother; 2008 Mar; 42(3):450-1. PubMed ID: 18230702 [No Abstract] [Full Text] [Related]
11. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection. Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W; Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594 [TBL] [Abstract][Full Text] [Related]
13. [Experience in the prophylactic use of ceftriaxone in pediatric surgery]. Inserra A; Zaccara A; Mosiello G; Serventi P; Boglino C Minerva Chir; 1990 May; 45(10):743-6. PubMed ID: 2388720 [TBL] [Abstract][Full Text] [Related]
14. [Ceftriaxone in the therapy of suppurative meningitis in childhood]. Pecco P; Pavesio D Minerva Pediatr; 1985 Aug; 37(15-16):561-3. PubMed ID: 4058391 [No Abstract] [Full Text] [Related]
15. Concentration of ceftriaxone in relation to the time of administration. Simonis G; Wolf N; Kayser M; Kalweit G; Filopoulos E Chemioterapia; 1987 Jun; 6(2 Suppl):264. PubMed ID: 3509407 [No Abstract] [Full Text] [Related]
16. Pharmacokinetics of ceftriaxone after intravenous administration to CAPD-patients with and without peritonitis. Favre H; Probst P Chemioterapia; 1987 Jun; 6(2 Suppl):273-4. PubMed ID: 3509411 [No Abstract] [Full Text] [Related]
17. [Transient cholelithiasis with the use of ceftriaxone]. Kuiper H; Meyboom RH; Jansen A Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1857-8. PubMed ID: 3185774 [No Abstract] [Full Text] [Related]
18. Ceftriaxone: use in multidrug resistant typhoid fever. Mishra S; Niranjan S; Kumar H; Sharma D Indian Pediatr; 1993 Jan; 30(1):67-70. PubMed ID: 8406711 [No Abstract] [Full Text] [Related]
19. [Ceftriaxone in the treatment of severe infections]. Germain M; Chaton P; Gobez N; Daversin P; Akli J; Coulée MD Cah Anesthesiol; 1986 May; 34(3):263-5. PubMed ID: 3742315 [No Abstract] [Full Text] [Related]
20. [Evaluation of the efficacy and tolerance of ceftriaxone in childhood]. Dellepiane RM; Maltagliati F; Ogliari MT Pediatr Med Chir; 1984; 6(6):785-9. PubMed ID: 6545591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]